Alerts:  June 13, 2025: Construction work on the SRHD College Avenue building begins on Monday, June 16, and is expected to continue for eight weeks. Please be mindful of areas around the building that are closed for safety.   |  Some federal websites are experiencing disruptions while being reviewed for compliance with President Trump’s executive orders. As a result, some links and information on srhd.org may be unavailable.

Pertussis Advisory for Health Care Providers

Increase in Pertussis Cases

Posted May 17, 2024. Past health advisories and alerts are archived for historical purposes and are not maintained or updated.

Current Situation in Washington and North Idaho

There have been a total of 170 confirmed and probable cases reported statewide during 2024 as of 5/4/2024 (CDC Week 18), compared to 24 cases during the same period in 2023, an increase of 6-fold. Multiple jurisdictions have reported increases.

Additionally, Panhandle Health District is reporting an increase in confirmed cases of pertussis in North Idaho. 04/24/2024: Whooping Cough on the Rise – Panhandle Health District

Persons at high risk for pertussis

  • Infants <1 year old (who are at greatest risk for severe disease and death)
  • Pregnant persons in the last trimester (who may expose infants)
  • Healthcare workers with direct patient contact (who may expose infants, pregnant persons, or others who have contact with infants or pregnant persons)
  • Anyone who may expose infants < 1 year old or pregnant persons (e.g., childbirth educators, childcare workers, members of a household with infants).

Actions Requested

  • Be aware of an increase in pertussis reported in some areas of Washington State and North Idaho, and that patients with a history of receiving pertussis vaccine can still get pertussis. Consider the diagnosis of pertussis in the following situations:
    • Respiratory symptoms in infants <12 months, especially if accompanied by difficulty feeding or apnea.
    • A cough illness, in patients of any age, that is characterized by one or more of the following:
      • Paroxysms
      • Gagging, post-tussive emesis, or inspiratory whoop
      • A duration of 2 weeks or more
    • Respiratory illness of any duration in patients who have had contact with someone known to have had pertussis or symptoms consistent with pertussis.
  • Consider testing. Collect a nasopharyngeal swab for pertussis polymerase chain reaction (PCR) or culture. PCR is the most sensitive and fastest diagnostic test. Culture is the most specific option, but not the most sensitive, and is rarely done. Note that serology should not be used for diagnosing pertussis cases in Washington.
    • Please note that a negative pertussis PCR or culture result cannot rule out pertussis. Treatment and case reporting may still be warranted, even with negative test results, per clinician’s assessment.
    • CDC provides information about best practices for using PCR to diagnose pertussis.
  • Report clinically-suspected pertussis cases within 24 hours to SRHD, who will assist you in determining recommendations for prophylaxis and exclusion.
  • Assure children and adults are up to date on pertussis-containing vaccine as recommended by national guidelines. Current vaccine schedules can be found on the CDC Immunization Schedules webpage.
    • Prioritize vaccination of household members and other close contacts of infants.
    • Tdap is recommended during each pregnancy after 20 weeks gestation (ideally during weeks 27 through 36).

Diagnosing pertussis can be difficult, particularly during the early (catarrhal) stage of illness, which features non-specific symptoms and may not initially include a cough. For a patient with respiratory symptoms, known or suspected exposure to pertussis should prompt inclusion of pertussis in the differential diagnosis. The incubation period for pertussis ranges from 5 to 21 days. A key feature that distinguishes pertussis from other common respiratory illnesses is the duration of the cough (usually longer than two weeks and can last 10 weeks or longer).

Resources for Providers

To report suspected cases, or for any other questions about pertussis, please contact:

SRHD 24/7 Reporting Line: 509.324.1449
Questions – SRHD Epidemiology: 509.324.1442
Fax: .509.324.3623
Email: CDEpi@SRHD.org